C4A and cancer: Nevertheless, we acknowledge that while anti-tumor effects of C4 serve as a proof of principle for the efficiency of pharmacological interference with IGF2BP2 activity for cancer treatment, C4 is not likely to serve as an actual drug for cancer therapy.